BEAT saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on February 14, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 26 instances where the indicator turned negative. In of the 26 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .
The Momentum Indicator moved below the 0 level on February 13, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on BEAT as a result. In of 57 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The 50-day moving average for BEAT moved below the 200-day moving average on February 18, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BEAT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
BEAT broke above its upper Bollinger Band on February 05, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where BEAT advanced for three days, in of 137 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 64 cases where BEAT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. BEAT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.586) is normal, around the industry mean (30.949). P/E Ratio (149.254) is within average values for comparable stocks, (161.461). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.763). Dividend Yield (0.000) settles around the average of (0.086) among similar stocks. P/S Ratio (5.999) is also within normal values, averaging (58.478).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BEAT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.
a wireless medical technology company, which focuses on the delivery of health information
Industry PackagedSoftware
A.I.dvisor tells us that BEAT and LIQQF have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BEAT and LIQQF's prices will move in lockstep.
Ticker / NAME | Correlation To BEAT | 1D Price Change % | ||
---|---|---|---|---|
BEAT | 100% | -1.42% | ||
LIQQF - BEAT | 29% Poorly correlated | N/A | ||
DSGX - BEAT | 29% Poorly correlated | -1.50% | ||
FICO - BEAT | 29% Poorly correlated | -1.59% | ||
AEYE - BEAT | 27% Poorly correlated | -5.06% | ||
PDFS - BEAT | 26% Poorly correlated | -6.31% | ||
More |